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Abstract 
 
Hydroxyapatite [Ca10(PO4)6(OH)2, HA] is used in many biomedical applications including 
bone grafts and joint replacements.  Due to its structural and chemical similarities to human 
bone mineral, HA promotes growth of bone tissue directly on its surface. Substitution of 
other elements has shown the potential to improve the bioactivity of HA.  Magnetron co-
sputtering is a physical vapour deposition technique which can be used to create thin coatings 
with controlled levels of a substituting element. Thin films of titanium-doped hydroxyapatite 
(HA-Ti) have been deposited onto silicon substrates at three different compositions. 
 
With direct current (dc) power to the Ti target of 5, 10, and 15W films with compositions of 
0.7, 1.7 and 2.0 at.% titanium were achieved. As-deposited films, 1.2 µm thick, were 
amorphous but transformed into a crystalline film after heat-treatment at 700C. Raman 
spectra of the PO4 band suggests the titanium does not substitute for phosphorous. X-ray 
diffraction revealed the c lattice parameter increases with additional titanium content. XRD 
traces also showed titanium may be phase separating into TiO2, a result which is supported 
by analysis of the Oxygen 1s XPS spectrum.  
 
In-vitro observations show good adhesion and proliferation of human osteoblast (HOB) cells 
on the surface of HA-Ti coatings. Electron microscopy shows many processes (i.e. filopodia) 
extended from cells after day one in-vitro and a confluent, multi-layer of HOB cells after day 
three. These finding indicate that there may be potential for HA-Ti films as a novel implant 
coating to improve upon the bioactivity of existing coatings.  
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Chapter 1 
 
Introduction 
 
1.1 Background 
 
The desire to introduce man-made materials into the treatment of the human body has 
prompted a wave of research into the field of biomaterials. An ever-present challenge in the 
area of biomaterials is to enhance the interface between biomaterial implants and the living 
tissue surrounding them. Some researchers in the field of orthopaedic biomaterials direct their 
focus on the fabrication and enhancement of bioactive properties of calcium-phosphates and 
in particular much interest has been directed towards the use of hydroxyapatite (HA).  
 
Calcium phosphate biomaterials are frequently used in the repair of the dental and 
musculoskeletal systems. In the case of the dental system HA has been used as a coating for 
tooth-root implants. In the musculoskeletal systems, calcium phosphates play a variety of 
roles from spinal fusions to the replacement of major load-bearing joints.  
 
Extended life-expectancies combined with increasingly active lifestyles have led to many 
bone-related ailments including increased susceptibility to bone fracture or excessive wearing 
of joints. As a result joint replacement surgeries have become omnipresent as a safe and 
effective way to improve the quality of life for patients suffering from joint ailments. One 
such type of joint replacement surgery is the total-hip arthroplasty (hip-replacement) which 
requires a metal stem (often titanium) to be fixed within the femur. The stem must be a strong 
material capable of bearing load and also integrating well with the surrounding bone tissue. 
Titanium implants themselves are harmless to the body, but do little to aid bone integration 
with the stem. One route to overcome this problem is to coat the implant with a material, such 
as HA, which mimics bone mineral thereby allowing the surrounding tissue to bond to the 
implant. 
 
A common commercial method for coating metal implants for use with bone is plasma-
spraying. While this technique is successful, it possesses a few drawbacks including the 
potential for the coating to delaminate. One alternative to plasma-spraying is sputtering, a 
physical vapour deposition technique, which yields excellent adhesion and uniform coverage 
to substrate materials. Sputtering also provides a simple method for doping calcium 
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phosphates with other ions at varying concentrations, an attractive option when designing 
substituted-HA. 
 
Substitutions to HA have been shown to improve osteoconductivity, thereby promoting better 
attachment and proliferation of bone-forming cells. In the 1970’s Carlisle et. al. showed that 
a Si-deficient diet led to poor bone mineralization and feather development in chickens. 
Researchers have since attempted to add silicon to HA to enhance its biological response and 
this choice of substitution has shown positive results (Thian et al. 2006, Gibson et. al 1999). 
Although the specific mechanism through which substitutions in HA enhance its bioactivity 
have yet to be fully understood, there are many other dopants which may prove beneficial to 
HA. One such substitution which has yet to be explored in great detail is that of titanium into 
HA. Some researchers are presently investigating ways to develop TiO2/HA hybrid coating 
due to the bioactive properties of both components. Such composites can be achieved by co-
sputtering titanium and HA onto a substrate.  
 
The successes that HA and TiO2 have shown in promoting growth and proliferation of bone 
tissue both separately and in combination with one another give way to the objective of this 
research. A new technique will be employed to combine HA and Ti to investigate the 
potential for producing titanium-doped HA coatings and determining their biological cell 
response. 
 
 
1.2  Objectives 
 
This research aims to complete the following tasks; 
 
1. Develop titanium-doped hydroxyapatite (HA-Ti) thin films by magnetron co-
sputtering. 
2. Investigate the effects of titanium doping on the crystal structure and surface chemistry 
of HA-Ti films. 
3. Observe the biological response to HA-Ti films in-vitro using human osteoblast-like 
cells. 
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1.3 Outline 
 
Chapter 1 of the thesis provides an overview and touches on the motivations behind this 
research. Chapter 2 provides an introduction to calcium-phosphates, in particular 
hydroxyapatite and its uses as an implant coating. Chapter 3 presents a survey of three 
methods used for making implant coatings with a focus on magnetron sputtering. Chapters 4 
to 6 present and discuss the experimental results obtained. Chapter 7 provides a linked 
discussion of all results. Chapters 8 and 9 present the conclusions and future work. 
 
The experimental section of this research is divided into three chapters. Chapter 4 provides a 
brief summary of the titanium-doped hydroxyapatite thin films produced by magnetron co-
sputtering. Chapter 5 is divided into sections corresponding to each characterization 
technique applied to samples: profilometry, energy dispersive x-ray spectroscopy, 
microscopy, x-ray diffraction, x-ray photoelectron spectroscopy, and Raman spectroscopy. 
Chapter 6 presents in-vitro observations of cell response to the HA-Ti thin films. 
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Chapter 2 
 
Calcium Phosphates as Coatings 
 
2.1 Calcium Phosphates 
 
Calcium phosphates (CaP) have been used for over 30 years in clinical applications (Shi 
2006). There are a variety of compounds in the CaP family, many of which are used in 
biomedical applications. The stability of CaP compounds is controlled by the ratio of calcium 
to phosphorous, the amount of water present, the temperature at which they are processed as 
well as the pH of the surrounding environment. The table below (Table 2.1) outlines a few 
CaP phases along with their chemical formula and Ca/P ratio (Fernandez 1999). 
 
Table 2.1 Examples of CaP phases for biomedical applications. 
Phase Formula Ca/P ratio 
Amorphous calcium phosphate (ACP) n/a n/a 
Octacalcium phosphate (OCP) Ca8(HPO4)2(PO4)4  · 5H2O 1.33 
Tricalcium phosphate ( or  TCP) Ca3(PO4)2 1.5 
Hydroxyapatite (HA) Ca2(PO4)6(OH)2 1.67 
 
Octacalcium phosphate is thought to be a biological precursor to apatite formation in bone 
and teeth (Brown 1962). OCP has been shown to convert to an apatite structure both in-vivo 
and in-vitro. A recent study demonstrated the important role of OCP in bone mineralization 
by showing improved bone formation on implanted OCP as compared to a hydrolyzed Ca-
deficient HA with respect to filling bone defects (Suzuki 2006).  
 
TCP is sometimes referred to by its chemical name calcium orthophosphate tribasic and 
exists as one of four polymorphs (, , and super-) (Gibson et al 1996). The  polymorph 
is a high-pressure phase while super- phase is observed at high temperatures (above 
1500C). Therefore it is mainly the  and  phases that are of interest as biomaterials. - and 
-TCP find application primarily in temporary scaffolds and in calcium phosphate bone 
cements. Bone cements, in general, are of interest because they are injectable, they can fill 
voids, and may serve as a resorbable scaffold material (Roemhildt 2006, Song 2007). It is 
also known that the dissolution of TCP is dependent upon its phase. In order of decreasing 
solubility -TCP > -TCP >> HA (Lin et al. 2001) which means under physiological 
conditions, HA is the most stable of the three materials.  
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Amorphous calcium phosphate is the least stable of the CaP phases in solution. It is typically 
the first phase formed during most rapid precipitation methods of forming CaP. ACP has 
been used in bone-cement (Takagi et al. 1998) as well as dental fillings (Dorozhkin 2007). 
Amorphous calcium phosphates have been used to develop mineral-releasing dental 
composites (Skrtic et al. 2004) as well as bone-implants for non-load bearing applications 
(Tadic et al. 2002). 
 
2.2 Hydroxyapatite 
 
Synthetic hydroxyapatite is similar in composition to the mineral component of bone and 
teeth. This similarity has led to interest in the development of HA materials for biomedical 
applications. The table below (Dorozhkin 2007) illustrates the chemical and structural 
similarities between HA, enamel, dentin, and bone. 
 
Table 2.2 Chemical and structural comparison of teeth, bone, and HA.  
Composition, wt% Enamel Dentin Bone HA 
Calcium 36.5 35.1 34.8 39.6 
Phosphorous 17.1 16.9 15.2 18.5 
Ca/P ratio 1.63 1.61 1.71 1.67 
Total inorganic (%) 97 70 65 100 
Total organic (%) 1.5 20 25 -- 
Water (%) 1.5 10 10 -- 
Crystallographic properties: Lattice parameters (0.003 Å) 
a-axis (Å) 9.441 9.421 9.41 9.430 
c-axis (Å) 6.880 6.887 6.89 6.891 
Crystallinity index, 
(HA=100) 
70-75 33-37 33-37 100 
 
  
Crystallographically, hydroxyapatite belongs to the hexagonal system with the P63/m space 
group. The ‘P’ indicates that HA is a primitive hexagonal system where a = b  c, 
 and  (Kay et al. 1964). A schematic representation of the crystal structure 
is provided in Figure 2.1 (Shi 2006). 
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Figure 2.1 Schematic representation of hydroxyapatite crystal structure. 
 
 
2.2.1  Use of HA as an Implant Coating 
 
Hydroxyapatite is known to be bioactive, meaning bone growth is supported directly on the 
material’s surface when placed next to bone. This response of hydroxyapatite sets it apart 
from the other CaP phases and has led to routine use in orthopaedic surgery in both powder 
and bulk form (Shi 2006). Wong et al. (1995) compared the osseointegration of commercial 
implants in the trabecular bone of mature miniature pigs for 12 weeks. Their results showed 
excellent osseointegration of the HA coated implant. More recent studies (Cao et al. 2006, 
Froimson et al. 2007) have also shown the successful osseointegration of HA coatings with 
surrounding bone tissue after an HA coated implant was placed within living bone. Cao et. al. 
produced HA coated carbon/carbon (carbon-fiber reinforced carbon) composites, an 
alternative to the traditional metal stem used in total-hip arthroplasties, and placed these 
implants into the tibia of rabbits. Froimson et al. recently concluded that plasma-sprayed HA 
coated titanium implants showed excellent osseointegration during 10-year follow ups of 147 
consecutive primary hip arthroplasties performed in 133 patients by a single surgeon during a 
2-year interval. 
 
While HA has demonstrated its ability to integrate with bone tissue it does not possess ideal 
mechanical properties to serve as a major load-bearing implant. Many orthopaedic implants 
are based on the use of metallic alloys such as stainless steel or titanium alloy. Metals, 
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however, do not form a direct bond with bone. Therefore there is interest in applying 
bioactive coatings to metal implants. 
 
2.2.2  Substituted Hydroxyapatite 
 
HA and bone mineral are somewhat different in composition and degree of crystallinity. 
Bone mineral is typically calcium deficient and contains carbonate substitutions. Other ions 
present in bone mineral include magnesium (Mg
2+
), sodium (Na
+
), potassium (K
+
), fluoride 
(F
-
), and chloride (Cl
-
) ions. It has been proposed that the more appropriate chemical formula 
for biological HA is (Ca, M)10(PO4, Y)6(OH, X)2 where M represents a substitution cation and 
X and Y represent substitution anions (Shi 2006). These substitutions may cause changes in 
properties such as crystallinity, solubility, and ultimately biological response. It is these 
changes in HA which have led researchers to enhance the biological response of HA through 
substitution. 
 
2.2.2.1 Carbonate 
 
Carbonate-substituted hydroxyapatite is believed to be more similar to bone mineral than 
pure HA and serves to decrease the crystallinity of the apatite while increasing its rate of 
dissolution. The mechanism for the substitution of the carbonate (CO3
2-
) ion into the HA 
lattice is well defined (Driessens 1983). There exist two types of carbonate substitutions, 
referred to as Type A and Type B substitutions. Type A substitution takes place when the 
carbonate ion replaces the hydroxyl (OH
-
) group whereas type B substitution takes place 
when the phosphate (PO4
3-
) group is replaced. Type A may be achieved by heat-treating HA 
in a carbon dioxide atmosphere whereas Type B may be formed by wet precipitation 
(Barralet et al. 1998) although it is more likely that both Type A and B substitutions occur. 
 
The two carbonate substitutions have opposite effects on the HA lattice parameter. During 
type A substitution the larger carbonate group sits on the smaller hydroxyl site, expanding the 
a-axis and contracting the c-axis (Romo 1954). During type B substitution the smaller 
carbonate group sits on the larger phosphate site, contracting the a-axis while expanding the -
c-axis. Figure 2.2 illustrates these changes (Shi 2006). 
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Figure  2.2 Changes in lattice parameter with respect to increasing carbonate substitution.  
 
Researchers have proposed models for a type AB substitution in which the a-axis lattice 
parameter contracts while the c-axis lattice parameter expands (Barralet et al. 1998, Fleet and 
Liu 2007). 
   
2.2.2.2 Magnesium 
 
The importance of ions such as magnesium, zinc, copper, iron, and fluoride for normal bone 
metabolism have been documented. With approximately 25 grams of Mg in the body, its role 
is small, but vital. Magnesium is believed to be integral for bone formation and resorption via 
reactions at the surface of bone mineral (Ilich et al. 2000).  Kakei et al. (1997) also 
demonstrated the importance of Mg in early-stage bone development through in-vivo tests.  
 
A study by Landi et. al. (2006) showed improved response of mesenchymal stem cells and 
MG-63 osteoblast-like cells with respect to adhesion, proliferation and metabolic activation 
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on 1 wt. % Mg–HA. More recently, Landi et al. (2007) have demonstrated biocompatible Mg 
substituted HA at 5.7 mol. % Mg.  Serre et al. (1998) presented some interesting findings 
when introducing Mg into hydroxyapatite. Results showed that high magnesium content (20 
wt.%) was cytotoxic to cell cultures during in-vitro testing and also suppressed the formation 
of a calcifying matrix around the cells.  
 
The substitution of Mg into CaP phases has also shown that the magnesium helps to stabilize 
the beta-tricalcium phosphate phase (Gibson et al. 2002, Kannan et al. 2007).  These findings 
are useful for those developing Ca-P bone cements. Mg substitution into CaP phases remains 
an active area of research.  
 
2.2.2.3 Silicon 
 
In the 1970’s and 80’s. Carlisle (1972, 1973, 1980) presented evidence that bone 
development was significantly hampered in chicks which were fed a silicon deficient diet. 
These findings were complemented by work which identified the presence of silicon in the 
bones of developing chicks and mice (Carlisle 1970, Landis et al. 1986). Since the initial 
finding regarding the role of silicon in bone development, efforts have been made to develop 
silicon-substituted hydroxyapatite. It is accepted that the silicon substitutes for the 
phosphorous in the HA unit cell as determined through FTIR studies of the absorption bands 
associated with the phosphate group (Gibson et al. 1999). 
 
Both in-vivo and in-vitro testing has been performed. In a study using a rabbit model the 
addition of 0.8 wt. % silicon to hydroxyapatite has shown improved bone ingrowth (37.5% ± 
5.9) compared to undoped HA (22.0% ± 6.5), as well as better bone/implant coverage (59.8% 
± 7.3) compared to HA (47.1% ± 3.6) (Patel et al. 2002). In addition to better coverage, the 
rate at which bone-cells adhere and proliferate on SiHA coatings has been investigated in-
vitro using human osteoblast-like cells (Thian et al. 2007). Results from Thian et al. show 
greater metabolic activity between days 2 and 4 on SiHA (up to 4.9 wt.% Si) samples as 
compared to undoped HA. 
 
Porter et al. (2003) investigated the dissolution of SiHA and observed the following trend 
with respect to rate of dissolution: 1.5 wt% Si-HA > 0.8 wt% Si-HA > undoped HA. It was 
reported that this trend is related to the quantity of triple junctions and grain boundaries 
present as a result of increased substitution.   
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2.2.2.4 Titanium 
 
TiO2 forms naturally as the native oxide layer on titanium alloys which are implanted into the 
body. This oxide layer serves to control the release of ions from the metal alloy, which in 
large quantities can be toxic to the human body. Kitsugi et al (1996) performed an in-vivo 
study using a rabbit model and observed improved bone-bonding ability of titanium implants 
when coated with TiO2. A study (Wen et al. 1998) later proposed that the attraction of OH
-
 
groups to TiO2 in aqueous solution plays a role in precipitation of CaP minerals. Li et al. 
(1996) also demonstrated the excellent bioactivity of TiO2 both in-vitro and in-vivo using sol-
gel coatings. 
 
The introduction of titanium into HA has not yet been approached from the perspective of a 
cationic substitution for the purpose of enhancing bioactivity. A study has recently been 
conducted in which titanium-substituted HA was formed for photocatalysis (Hu et al. 2007).  
As for biological coatings, some research (Lu et al. 2004) has been executed to develop 
hybrid coatings of plasma-sprayed HA and TiO2. The goal of this work was to improve the 
mechanical response of the coating while attempting to further buffer the underlying alloy 
from releasing ions into the surrounding system. The two components remain phase separated 
after heat treatment. TiO2 and HA composites formed by sol-gel have been tested for 
biocompatibility and cell response and results show the combination to be biocompatible and 
excellent at promoting cell activity (Ramires et al. 2001).   
 
A range of hydroxyapatite substitutions has been investigated to date. Some substitutions 
such as carbonate substitutions increase the solubility of the hydroxyapatite while other 
substitutions, such as fluorine and chlorine decrease solubility. Overall the objective of 
substituting HA is to promote bone ingrowth while leaving the structure stable enough for 
long-term in-vivo application. The effects of titanium substitution are yet undiscovered. 
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2.3  Studying the Bioactivity of Coatings 
 
In 1998 Larry Hench published a review of bioceramics in which he outlined the sequence of 
interfacial reactions which take place as tissue bonds to bioactive glass. Unfortunately there 
has not yet been a study which conclusively maps out the mechanism through which cell 
adsorption and proliferation takes place on hydroxyapatite. Many speculate as to the 
sequence of surface reactions which take place in the moments after an implant is placed in-
vivo, however in-vitro simulations can provide some insights.  
 
The benchmark for determining bioactivity of a bone-implant coating is whether the material 
promotes the crystallization of Ca-P-rich apatites once in solution. Many researchers test the 
rate of apatite formation on their biomaterials by conducting in-vitro studies using simulated 
body fluid (SBF). SBF is a buffered solution, created by Kokubo in the late 1980’s, 
containing various minerals and salts present in human plasma. Researchers use techniques 
such as inductively coupled plasma (ICP) to quantify the changes in ion concentration in the 
solution. This analysis is traditionally coupled with microscopy of the coating surface to 
observe changes in morphology due to apatite precipitation and XRD analysis to determine 
crystal structure of the newly formed apatite in addition to changes in coating crystallinity. 
Figure 2.3 shows precipitated calcium-phosphate on the surface of HA after being immersed 
in SBF as well as apatite formation after 12 weeks in-vivo (Porter et al. 2004a). 
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Figure 2.3 Precipitated Ca-P on the surface of bioactive HA:  
(a) Needle-like Ca-P precipitates form as the HA granule undergoes dissolution. The HA has 
been dispersed in simulated body fluid for 1 day.  
(b) HA which was placed in-vivo for 12 weeks promotes the formation of bone apatite around 
the implant interface without dissolving. 
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The next step when testing the bioactivity of newly developed coatings is to observe the cell 
response. Many studies now use primary human cell lines, such as the osteoblast-like cells 
taken from the MG-63 cell line, as the standard when studying cell adsorption and 
proliferation. Sterilised samples are covered with cells, allowed to grow, and then fixed on 
the substrate for electron microscopy. Fig 2.4a shows an MG-63 cell attached to a plain 
titanium alloy substrate while Fig 2.4b, on the other hand, shows MG-63 cells proliferating 
and spreading on a bioactive surface (Kim 2004). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.4 Cellular response to bioinert versus bioactive materials: (a) MG-63 cell retains 
spherical morphology and has not spread on the bare titanium substrate; (b) MG-63 cells 
have attached and proliferated on the bioactive surface. Filopodia extend from the base of the 
cells as they spread. 
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Chapter 3 
 
Review of CaP Coating Production Methods 
 
3.1  Introduction 
 
While hydroxyapatite and other CaP phases find a range of applications in the human body, 
one area of particular interest for researchers is to develop coatings for bone implants. Figure 
3.1 shows a metal implant used for hip arthroplasty including the region which is coated with 
HA (Jaffe and Scott 1996). There are three main categories of techniques for making 
hydroxyapatite coatings: plasma spraying, wet methods such as sol-gel, and physical vapour 
deposition, namely sputtering.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.1 Hip-replacement prosthesis 8 years after surgery (left)  
and original HA-coated titanium prosthetic (right).  
 
The common characteristics that are required of all coatings include the following: (i) good 
adhesion between the bioceramic and the metal implant, (ii) stable CaP phase to ensure 
longevity of the implant-bone fixation, (iii) uniform coating which may be used on complex 
shapes. 
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3.2 Plasma Spraying 
 
Plasma spraying is a popular and widely-used technique to apply CaP coatings to implants. It 
has gained popularity over the past two decades due to its economic efficiency and scalability 
for large-scale production (Sun et al. 2001). Plasma spraying is a technique in which a 
feedstock, HA in a powder form, is released into a carrier gas to be transported into the 
plasma gun. The gun generates the plasma by maintaining a high voltage across an ionisable 
gas, such as argon. The powder is partially melted in the plasma (temperatures can exceed 
10,000K) and is accelerated towards the substrate at which point the molten particles rapidly 
cool upon colliding with the substrate. Figure 3.2 shows a schematic of plasma spraying. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.2 Schematic of plasma spraying process. HA powder is fed into  
the plasma flame. The particles arrive with both high velocity and  
temperature at the substrate where they stack upon one another to build up the coating. 
 
 
One of the main concerns with plasma spraying is the degradation of hydroxyapatite particles 
into other less stable phases of CaP including tetra calcium phosphate, TCP, and amorphous 
CaP (Radin and Ducheyne 1992). Cao et al. (1996) demonstrated the effectiveness of water-
vapour heat treatments to convert these phases back to crystalline HA. As a result the coating 
became more stable when placed in solution than as-deposited coatings. To incorporate ion 
 
Cathode (+) 
Anode (-) 
Plasma Gas 
Plasma Arc 
HA Feedstock 
Molten particles 
 
Coating 
50-100m 
Chapter 3  Review of CaP Coating Production Methods 
16 
substitution into plasma-sprayed coatings, the feed powder must be substituted HA. Recent 
success (Xue et al. 2007) has been demonstrated with a plasma-sprayed strontium-substituted 
hydroxyapatite in which coatings with a thickness of 200-300 m, good adhesion to the 
titanium alloy substrate, and improved cell response as compared to undoped HA were 
achieved. 
 
During the plasma spraying process, the feedstock undergoes extreme conditions (i.e. 
temperatures in excess of 10,000 K). The variables which can be adjusted during plasma 
spraying include the size of the HA particles as well as the speed with which the particles 
travel towards the substrate. When the particles enter the plasma, they are accelerated 
towards the implant, during which time they undergo partial melting and decomposition. As a 
result, plasma sprayed coatings appear to include a range of crystalline HA as well as a range 
of CaP phases (Sun et al. 2001). 
  
Achieving the optimum thickness for plasma-sprayed coatings is critical; if the coating is too 
thick, the shear strength is compromised making adhesion to the implant weaker. Industry 
manufacturers aim for coatings of 50-75 m in thickness. (Sun et al. 2001). It has been 
demonstrated that plasma-sprayed coatings can delaminate over time which poses a problem 
to the longevity of bone-implant fixation. Furthermore, debris from a delaminated coating 
can negatively affect local bone development (Misch and Dietsh, 1993).   
 
3.3 Sol-gel and Biomimetic Processes 
 
Sol-gel is a method which begins with the mixing of precursors in a solvent. A heating stage 
is carried out to promote the formation of the desired compounds while driving off the 
organic components of the solvent leaving behind a coating. In the case of hydroxyapatite 
there are a variety of precursors that can be mixed together in an organic solvent such as 
ethanol. The sol is placed onto a substrate by spin or dip coating. After heating the sol and 
removing the solvent, the HA gel that is left over is calcined to ensure crystallinity. Typically 
this heat-treatment is carried out at low temperatures to prevent oxidation or phase change in 
a substrate.  
 
Liu et al. (2001) developed sol-gel based HA using triethyl phosphite and calcium nitrate. 
Each precursor was hydrolyzed in water and remained in solution until heated to 60C to 
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drive off the solvent. The remaining gel was then calcined at 350C to result in a porous, 
crystalline layer of HA.  The porous structure is believed to aid in the movement of 
physiological fluid through the coating in biomedical applications.   
 
Sol-gel is an excellent coating technique for complex shapes and results in a thin coating (e.g. 
< 1 m). However, the coating properties can vary greatly depending on the precursors used, 
the processing parameters chosen for the sol, temperature at which the films are processed, 
and the atmosphere in which the gel is heat-treated. Because the technique requires some 
heat-treatment to crystallize the coating, there is risk of oxidising the substrate. Therefore 
continued research in this area aims to produce crystalline coatings at the lowest temperatures 
possible. 
 
A biomimetic approach to making CaP coatings relies on the natural formation of an apatite 
layer on a substrate once immersed in simulated body fluid (Kokubo et al. 2003). Simulated 
body fluid (SBF) is similar in composition to human blood plasma. By placing substrates in 
this solution at 37C, a layer of apatite can be crystallized and grown. The process is 
inexpensive, simple to execute, and does not require high temperature processes or harsh 
chemicals. The drawback, however, is the length of time (e.g. days) needed to grow a 
sufficiently thick apatite layer from solution. 
 
Lu et al. (2007) investigated the effects of a nitric acid treatment on titanium substrates to 
increase surface area for nucleation and growth of a Ca-P layer. Samples were tested in both 
simulated body fluid and a supersaturated calcium phosphate solution (SCPS). Results 
showed an amorphous layer of CaP in the SBF and an octacalcium phosphate layer in the 
SCPS. The CaP layer showed signs of delamination if the substrate was not of sufficient 
roughness. A rougher substrate increases surface area and yields better coating to substrate 
adhesion.  
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3.4 Principles of Magnetron Sputtering  
 
The category of physical vapour deposition includes techniques such as evaporation, e-beam 
evaporation, pulsed laser deposition, and sputter deposition. For the purposes of this research 
sputtering will be looked at in closer detail. Magnetron sputtering affords a range of 
advantages including: (i) good adhesion and high density of films, (ii) ability to deposit 
metals, oxides, etc. with control over composition and stoichiometry, and (iii) high thickness 
uniformity and stability of deposition rate (Kukla 1997) 
 
There are three basic components needed to make a sputtering system. The first component is 
a vacuum chamber. These chambers are generally made of steel and are sealed with copper 
gaskets for isolation from the surrounding atmosphere. The chamber is connected to a 
pumping system to evacuate the chamber of air and achieve an ultra-high vacuum. Once a 
clean vacuum is achieved, the inert sputtering gas, argon for example, is released into the 
chamber at a controlled rate. It is this gas which creates the plasma necessary for the 
sputtering to take place. 
 
The second component of a sputtering system is a holder upon which the substrates will be 
placed once in the chamber. This holder is sometimes attached to an external system to 
control its temperature. The distance between the substrate holder and the sputtering target is 
a variable which must be controlled. It may be advantageous to have a rotating substrate 
holder to achieve uniformity. 
 
The final component of the system is the sputtering target from which the atoms will be 
deposited onto the substrates. The target can be almost any material. To strike a plasma from 
the argon gas in the vacuum chamber the following conditions must be reached: the system 
must be at a low pressure (e.g. 0.5 – 5 Pa) and there must be a high negative voltage on the 
target (i.e. kV). The sputtering gas breakdowns into ions which are accelerated towards the 
target in the presence of the strong electric field. 
 
These ions bombard the sputtering target releasing atoms or clusters of atoms. Secondary 
electrons, in addition to atoms, are released from the target. These electrons collide with inert 
gas near the target promoting a self-sustaining glow discharge. A magnet is present behind 
the target. The magnetic field lines penetrate the target and act to confine the electrons at the 
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target surface and as a result increase the rate of sputtering at the target surface. The sputtered 
atoms move away from the target. Some atoms are scattered while others deposit onto the 
substrates creating a thin film. Figure 3.3 provides a schematic of the sputtering process. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.3 Schematic diagram illustrating magnetron sputtering system. 
 
 
There are several variables during deposition which impact the rate at which the target is 
sputtered and material is transferred to the substrate. The primary method to control 
deposition rate is to adjust the power supplied to the target. Sputtering is most efficient when 
the mean free path of sputtered atoms is as large as possible while still maintaining a steady 
plasma. If the chamber pressure is increased, more ionised gas will collide with the sputtered 
material reducing the flux of atoms arriving at the substrate. The other variable, which can be 
adjusted, is the target-substrate distance. A shorter target-substrate distance will increase the 
rate of deposition, but at the expense of film uniformity. The substrates will also undergo 
heating as they are moved closer to the target. 
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3.5 Physicochemical Properties of Sputtered Coatings 
 
Calcium phosphate coatings were prepared by magnetron sputtering as early as 1993 by 
Jansen and colleagues. In the years after the introduction of this deposition method, much 
research has been done to manipulate deposition conditions and heat treatments to optimize 
the coating properties. 
 
Sputtered coatings of calcium-phosphate have shown higher than expected Ca/P ratios. Ozeki 
and colleagues (2002) prepared coatings sputtered from a stoichiometric hydroxyapatite 
target with calcium-phosphate (Ca/P) ratio of 1.67 (prepared by wet precipitation and 
crystallized at 900C). The target-substrate distance was 60mm. The deposition pressure was 
varied from 0.5 to 5 Pa and target power density varied from 2.54 to 7.64 W cm
-1
. Ca/P ratios 
(obtained by energy-dispersive x-ray spectroscopy, EDS) as high as 2.43 ± 0.07 were 
observed, values significantly higher than that of the stoichiometric target. 
 
van Dijk (1996) prepared 2 m thick samples of sputtered calcium phosphate from a plasma-
sprayed target. Rutherford backscattered spectrometry (RBS) was used to obtain the Ca/P 
ratio. As deposited samples had a Ca/P ratio of 2.1 as compared to the stoichiometric 1.67 for 
HA. Heat treatments reduced the Ca/P ratio, however the stoichiometric value could not be 
obtained.  
 
To counter the higher Ca/P ratio from sputtered hydroxyapatite van Dijk et al. (1997) took a 
different approach. van Dijk and colleagues prepared thin coatings of sputtered Ca5(PO4)3OH 
using a plasma-sprayed target. Ti6Al4V discs were used as substrates and the target-substrate 
distance was set at 75 mm. The deposition variables included pressure (0.3 and 1.5 Pa) and 
power level. Sputtering time was 2 hours and oxygen was added to the sputtering chamber at 
5, 10, and 50% of the argon pressure. The additional oxygen reduced the deposition rate and 
also suppressed the preferential re-sputtering of phosphorous from the film thus bringing the 
Ca/P ratio to the stoichiometric 1.67 desired of HA coatings.  
 
More recently Boyd et al. (2007) produced a range of magnetron sputtered calcium-
phosphate samples with a range of Ca/P ratios by adjusting the pressure of the argon 
sputtering gas during deposition. The objective of this study was to use multiple HA targets 
during deposition combined with different pressures to achieve a variety of Ca/P coatings. 
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The samples were heat-treated to 500C for two hours.  The composition of films was 
determined using x-ray photoelectron spectroscopy (XPS), a technique which is not 
traditionally used to obtain the Ca/P ratio, which gave Ca/P ratios for heat-treated samples 
ranging from 3.38 ± 0.11 (1 Pa) to 1.82 ± 0.06 (5 Pa). The stoichiometric Ca/P ratio of HA is 
1.67 as presented in Table 2.1.  
 
3.5.1 Heat treatment of Sputtered Coatings 
 
The post-deposition heat treatment of sputtered films is critical to achieve a crystalline film. 
van Dijk and colleagues (1996) investigated the effects of different heat treatments on 
sputtered calcium phosphate coatings. 2 m thick samples were formed by sputtering. 
Samples were heat treated under an argon and argon-water vapour atmosphere at 
temperatures of 400, 600, 800, 1000, and 1200C. Results showed the samples formed 
crystalline HA at 600C in both argon and argon-water vapour atmospheres.  
 
More recently Yang et al. (2003) conducted a similar investigation on the crystallinity of 
calcium phosphate coatings as a function of temperature and the presence of water vapour. 
Using XRD they found a difference in the degree of crystallinity, 68% as opposed to 2%, 
when water vapour is present at 450C. At temperatures above 450C it was concluded that 
the presence of water vapour did not have a significant effect on crystallinity.  
 
3.5.2 In-vivo Study of Sputtered Coatings 
 
Wolke et al. (1997) prepared sputtered Ca-P coatings on pure titanium discs using a plasma-
sprayed target. Coatings at thicknesses of 0.1, 1, and 4 m were sputtered with an r.f. power 
source. Half of the samples were heat treated at 500C for 2 hours. The discs were prepared 
so they could be implanted into rabbits to study the in-vivo dissolution of the coatings. It was 
discovered that as-deposited coatings dissolved too rapidly. Heat-treated samples dissolved at 
an optimal rate in-vivo and showed signs of apatite growth on the coating during the study. 
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3.5.3 Sputtering of Doped-Hydroxyapatite Thin Films 
 
The importance of substitutions into HA (Section 2.2.2) have been presented in addition to 
various techniques to make implant coatings. Traditional methods for forming doped 
hydroxyapatite have focused on wet precipitation. Recently, substituted or doped 
hydroxyapatite coatings have been developed through magnetron sputtering (Chen et al. 
2006, Porter et al. 2004b, Thian et al. 2005, 2006). There are two ways in which a substituted 
hydroxyapatite could be sputtered. One method would be to fabricate a doped target from 
which the coating could be deposited. This route would be intensive and would restrict the 
composition of doped films. The more popularly adopted alternative is magnetron co-
sputtering. 
 
Porter et al. (2004b) developed the first silicon-substituted hydroxyapatite thin films using 
magnetron co-sputtering. Thin films (100 to 150 nm) were fabricated by depositing at a rate 
of 0.85 nm/min at a pressure of 0.85 Pa. The phase-pure HA target was slip-cast and sintered 
and the commercial Si target was 99.999% pure.  
 
This work was then advanced by Thian et al. (2005) in which films of 600 nm doped with 0.8 
wt.% Si were formed by co-sputtering. As-deposited films were heat-treated for 3 hours in a 
700C argon-water vapour atmosphere. Crystalline films, confirmed by XRD, were then 
placed in-vitro with human osteoblast-like cells. These cells showed optimal response on 
heat-treated Si-substituted HA films. Thian et.al  (2006) extended their work to make 
coatings with 0.8, 2.2 and 4.9 wt. % silicon. Osteoblast attachment, proliferation, and 
differentiation during this long-term in-vitro study showed great promise for these co-
sputtered coatings to be used in-vivo. 
 
Chen and colleagues (2006) developed functionalized hydroxyapatite coatings by 
investigating the antibacterial properties of silver when added to HA.  To address the issue of 
bacterial infection after implant procedures, a co-sputtered coating of hydroxyapatite and 
silver was created. After a 3 hour deposition of Ag (10W) and HA (300W) a 4 hour heat 
treatment at 400 C created crystalline HA with phase separated silver. The doped coating 
appeared to inhibit the growth of bacteria in-vitro. No cytotoxicity of the coatings was 
observed.  
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3.6 Summary 
 
While many techniques may be used to develop Ca/P coatings for use in biomedical implants, 
magnetron co-sputtering provides the opportunity to easily develop a range of doped 
hydroxyapatite coatings. A wide range of characterization methods have been applied to the 
study of HA. Profilometry and EDS are commonly used methods for determining the 
thickness and composition of Ca/P coatings. Fourier-transform Infrared Spectroscopy (FTIR) 
provides detailed information on the molecular structure of HA, but requires operation in 
glancing-angle or reflection mode for thin films. Raman spectroscopy has not been used 
extensively with HA, but provides similar information to FTIR regarding molecular structure. 
XPS provides analysis of the surface chemistry of coatings and can provide insight into the 
bonding state of atoms present. XRD has become a commonly accepted method for 
investigating the crystallinity of HA. 
 
It was the intention of this project to use the versatility of magnetron co-sputtering to 
investigate the effects on hydroxyapatite when doped with a small amount of titanium. A 
range of characterization techniques (profilometry, EDS, XRD, XPS, Raman Spectroscopy) 
will elucidate some of the materials properties of HA-Ti coatings. Preliminary human 
osteoblast cell response to HA-Ti coatings will be observed in-vitro. 
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Chapter 4 
 
Experimental Methods for Film Fabrication 
 
4.1 Substrates & Targets 
 
Polished single crystal (100) silicon was manually cleaved using a diamond scribe into 
squares approximately 1cm by 1cm to be used as substrates. Silicon (Si) was selected as the 
substrate material because it is easy to cleave and it is stabile at high temperatures. Silicon 
substrates also have a smooth, polished surface meaning a step height can be easily measured 
when determining film thickness. Should work be carried out to determine the release rate of 
titanium atoms from the hydroxyapatite films, the substrate cannot be made of titanium.  
 
Substrates were cleaned in an ultrasonic acetone bath for 3 minutes and dried with 
compressed air. Approximately 20-25 substrates were positioned together on the substrate 
holder during each deposition. A titanium (Ti, 99.6% pure) target along with a homemade 
hydroxyapatite (HA) target were used as sputtering targets with dimensions of 55mm by 35 
mm.  
 
The HA target was slip-cast from a slurry of precipitated HA and sintered to form a dense, 
single-phase target. (prepared by Junyi Ma, Cambridge Centre for Medical Materials).  The 
precipitated HA powder was dried and calcined. The calcined powder was then suspended in 
deionised water and polymer dispersant before undergoing a 3–day ball milling process. The 
slurry was then poured onto a plaster plate within a mold. After adequate drying, the target 
was sintered (120°C for 4 hours to eliminate water in samples followed by 1200°C for 2 
hours). The sample was polished down to dimensions of 55mm by 35mm by 2-3mm, cleaned 
in acetone, and oven dried. The target was characterized with XRD and EDS which showed a 
phase-pure HA target with a Ca/P ratio of approximately 1.67. 
 
4.2 Magnetron Co-sputtering 
 
HA-Ti coatings were prepared using a customized deposition system with two targets. Both 
the HA and Ti targets were affixed to water-cooled magnetrons with a separation distance of 
105mm. The Si substrates were placed on a flat substrate-holder 44mm below the targets. 
The chamber was evacuated using a rotary roughing pump followed by a turbo-molecular 
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pump bringing the base pressure to 1 x 10
-7
 Pa after an overnight pump. The deposition was 
carried out at room temperature while a continuous flow of high-purity argon (Ar) gas was 
delivered into the sputtering chamber maintaining the working pressure at 0.8 Pa. The 
sputtering time for all depositions was 6 hours.  
 
The radio-frequency power (13.56 MHz) supplied to the HA target was limited to 60 W (3.11 
W cm
-2
). At higher power the ceramic target was likely to heat and crack. The deposition rate 
from this ceramic target was very low in comparison to the metallic Ti target. To achieve 
various concentrations of Ti in the thin films, the direct-current power to the Ti target was 
supplied at 5, 10 and 15 W. The power supply used for direct-current (dc) sputtering was 
unstable when supplying power below 5W and would have prevented reproducible results. 
 
Both targets were pre-sputtered while a rotatable shutter shielded the substrates. Pre-
sputtering took place for approximately 10 minutes prior to starting the deposition to remove 
any adsorbed contaminants from the surface of the targets and to allow the deposition 
parameters to be set (i.e. pressure and power). Co-sputtering of both the HA and Ti targets at 
equal rates would result in Ti concentrations beyond the desired amount. To reduce the rate 
of Ti deposition, a shutter with holes was placed in front of the Ti target during deposition to 
reduce the flux of Ti atoms arriving at the substrates. The substrates were also placed in front 
of the HA target to reduce the flux of titanium even further. A composition gradient was 
avoided by placing all substrates within a narrow region beneath the HA target. Figure 4.1 
presents a schematic of the deposition chamber. 
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4.3 Heat Treatment 
 
As- deposited samples underwent two different heat treatments in tube furnaces. Samples 
were heated at a rate of  2.5 C /min to a temperature of 700 C and maintained for 4hrs. The 
furnace atmosphere was either an argon gas or a water vapour-argon mixture (Ar + H2O). 
The water-vapour was introduced into the sealed tube-furnace by bubbling argon through a 
flask of deionised water before it entered the furnace. Table 4.1 outlines the atmosphere and 
deposition conditions for various samples.  
 
Table 4.1 Crystallization atmosphere and sputtering conditions for HA-Ti films. 
Sample Ti-power (W) Atmosphere 
A1 5 Ar 
A2 10 Ar 
A3 15 Ar 
B1 5 Ar + H2O 
B2 10 Ar + H2O 
B3 15 Ar + H2O 
   Ti-power: direct-current power to Ti target 
   Temperature: 700C for all samples 
   Heat treatment dwell time = 4hrs 
   Radio-frequency power to HA target = 60W 
 
 
For XPS analysis (Section 5.4) a sample was heated to 500C for 2hrs in an argon-water 
vapour atmosphere. 
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